SCHEMBL26423558

SCHEMBL26423558

c1ccc2cc3c(cc2c1)sc1ncccc13

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.41
CYP3A4 P08684 1/20 0.39
LIMK1 P53667 3/20 0.39
ALDH1A1 P00352 5/20 0.39
CLK1 P49759 2/20 0.38
IKBKB O14920 1/20 0.38
CHUK O15111 1/20 0.38
CDC7 O00311 1/20 0.38
DBF4 Q9UBU7 1/20 0.38
CCR1 P32246 2/20 0.36
CCR8 P51685 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PDK1 Q15118 1/20 0.36
NPC1 O15118 2/20 0.35
LMNA P02545 2/20 0.35
TSHR P16473 1/20 0.35
RAB9A P51151 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26423589 0.86 NPC1 (0.42) CYP2A6CYP3A4LIMK1ALDH1A1CLK1
SCHEMBL26423595 0.86 NPC1 (0.42) CYP2A6CYP3A4LIMK1ALDH1A1CLK1
SCHEMBL26423582 0.85 CLK1 (0.42) CYP2A6LIMK1CLK1IKBKBCHUK
SCHEMBL26423584 0.85 CLK1 (0.42) CYP2A6LIMK1CLK1IKBKBCHUK
SCHEMBL25461786 0.80 NPC1 (0.39) CYP2A6LIMK1NPC1LMNARAB9A
SCHEMBL25461775 0.80 NPC1 (0.39) CYP2A6LIMK1NPC1RAB9AKDM4E
SCHEMBL30376713 0.79 GPR3 (0.54) LIMK1ALDH1A1CLK1IKBKBCHUK
SCHEMBL3378060 0.79 GPR3 (0.54) LIMK1ALDH1A1CLK1IKBKBCHUK
SCHEMBL20042621 0.79 ALDH1A1 (0.35) CYP2A6CYP3A4ALDH1A1CCR1CCR8
SCHEMBL26423577 0.77 LIMK1 (0.41) CYP2A6CYP3A4LIMK1ALDH1A1CLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL OCIAD2, OCIAD1, AZI2 CYP2A6 1228/4885CYP3A4 709/4885LIMK1 1525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.